• Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. • The move reflects a broader industry shift toward consolidation and integrated care, as large healthcare companies seek scale and more continuous clinical data inside hospitals. • The post Danaher Drops $10B to Snatch Masimo in Diagnostics Push appeared first on MedCity News .
Article Summaries:
- Danaher has agreed to acquire Masimo for $10 billion, expanding its diagnostics portfolio and strengthening its presence in acute‑care settings. The purchase reflects a broader industry trend toward consolidation, as large healthcare firms seek scale and integrated, continuous clinical data streams within hospitals. By adding Masimo’s pulse‑oximetry and related technologies, Danaher aims to deliver more comprehensive diagnostic solutions to clinicians. The deal underscores the sector’s focus on integrated care and data‑driven decision making.
Sources: